CIK 0001846253 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
OmniAb, Inc.
Sign in to watch- Ticker
- OABI
- Exchange
- Nasdaq
- Industry
- Services-Commercial Physical & Biological Research
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 510-250-7800
- Business address
- 5980 HORTON STREET, SUITE 600, EMERYVILLE, CA, 94608
- Former names
- Avista Public Acquisition Corp. II
Securities
- OABI Common Stock Nasdaq
- OABIW Warrant Nasdaq
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 49 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-11-01 | HIGGINS JOHN L Director | Grant or award | +2,427,861 | 2,603,965 | ||
| 2022-11-01 | FOEHR MATTHEW W President and CEO | Grant or award | +1,431,618 | 3,296,665 | ||
| 2022-11-01 | Berkman Charles S Chief Legal Officer | Grant or award | +366,511 | 305,412 | ||
| 2022-11-01 | Cochran Jennifer R. Director | Grant or award | +25,518 | 93,378 | ||
| 2022-11-01 | Boyce Sarah Director | Grant or award | +39,628 | 48,381 |
Page 15 of 15 · 285 trades